Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen r...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d5a2f8f936e9455eb7b76ffab63946c1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d5a2f8f936e9455eb7b76ffab63946c12021-11-25T16:49:07ZBispecific T-Cell Engagers Targeting Membrane-Bound IgE10.3390/biomedicines91115682227-9059https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c12021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1568https://doaj.org/toc/2227-9059The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen receptor on B cells, and the interaction with low-affinity IgE receptor CD23 additionally influences its homeostatic range. Therapeutic anti-IgE antibodies act by the inhibition of IgE functions by interfering with its receptor binding or by the obliteration of IgE-B cells, causing a reduction of serum IgE levels. Fusion proteins of antibody fragments that can act as bispecific T-cell engagers have proven very potent in eliciting cytotoxic T-lymphocyte-mediated killing. We have tested five anti-IgE Fc antibodies, recognizing different epitopes on the membrane-expressed IgE, for the ability to elicit specific T-cell activation when expressed as single-chain Fv fragments fused with anti-CD3ε single-chain antibody. All candidates could specifically stain the cell line, expressing the membrane-bound IgE-Fc and bind to CD3-positive Jurkat cells, and the specific activation of engineered CD3-overexpressing Jurkat cells and non-stimulated CD8-positive cells was demonstrated for 8D6- and ligelizumab-based bispecific antibodies. Thus, such anti-IgE antibodies have the potential to be developed into agents that reduce the serum IgE concentration by lowering the numbers of IgE-secreting cells.Aleksandra RodakGerhard StadlmayrKatharina StadlbauerDominic LichtscheidlMadhusudhan Reddy BobbiliFlorian RükerGordana Wozniak-KnoppMDPI AGarticleanti-IgE antibodiesbispecific T-cell engagerscytotoxic T-lymphocyte mediated killingextracellular membrane-proximal domainFcεT-cell activationBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1568, p 1568 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
anti-IgE antibodies bispecific T-cell engagers cytotoxic T-lymphocyte mediated killing extracellular membrane-proximal domain Fcε T-cell activation Biology (General) QH301-705.5 |
spellingShingle |
anti-IgE antibodies bispecific T-cell engagers cytotoxic T-lymphocyte mediated killing extracellular membrane-proximal domain Fcε T-cell activation Biology (General) QH301-705.5 Aleksandra Rodak Gerhard Stadlmayr Katharina Stadlbauer Dominic Lichtscheidl Madhusudhan Reddy Bobbili Florian Rüker Gordana Wozniak-Knopp Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
description |
The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen receptor on B cells, and the interaction with low-affinity IgE receptor CD23 additionally influences its homeostatic range. Therapeutic anti-IgE antibodies act by the inhibition of IgE functions by interfering with its receptor binding or by the obliteration of IgE-B cells, causing a reduction of serum IgE levels. Fusion proteins of antibody fragments that can act as bispecific T-cell engagers have proven very potent in eliciting cytotoxic T-lymphocyte-mediated killing. We have tested five anti-IgE Fc antibodies, recognizing different epitopes on the membrane-expressed IgE, for the ability to elicit specific T-cell activation when expressed as single-chain Fv fragments fused with anti-CD3ε single-chain antibody. All candidates could specifically stain the cell line, expressing the membrane-bound IgE-Fc and bind to CD3-positive Jurkat cells, and the specific activation of engineered CD3-overexpressing Jurkat cells and non-stimulated CD8-positive cells was demonstrated for 8D6- and ligelizumab-based bispecific antibodies. Thus, such anti-IgE antibodies have the potential to be developed into agents that reduce the serum IgE concentration by lowering the numbers of IgE-secreting cells. |
format |
article |
author |
Aleksandra Rodak Gerhard Stadlmayr Katharina Stadlbauer Dominic Lichtscheidl Madhusudhan Reddy Bobbili Florian Rüker Gordana Wozniak-Knopp |
author_facet |
Aleksandra Rodak Gerhard Stadlmayr Katharina Stadlbauer Dominic Lichtscheidl Madhusudhan Reddy Bobbili Florian Rüker Gordana Wozniak-Knopp |
author_sort |
Aleksandra Rodak |
title |
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
title_short |
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
title_full |
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
title_fullStr |
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
title_full_unstemmed |
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE |
title_sort |
bispecific t-cell engagers targeting membrane-bound ige |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c1 |
work_keys_str_mv |
AT aleksandrarodak bispecifictcellengagerstargetingmembraneboundige AT gerhardstadlmayr bispecifictcellengagerstargetingmembraneboundige AT katharinastadlbauer bispecifictcellengagerstargetingmembraneboundige AT dominiclichtscheidl bispecifictcellengagerstargetingmembraneboundige AT madhusudhanreddybobbili bispecifictcellengagerstargetingmembraneboundige AT florianruker bispecifictcellengagerstargetingmembraneboundige AT gordanawozniakknopp bispecifictcellengagerstargetingmembraneboundige |
_version_ |
1718412985221775360 |